Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
USCT Stock Summary
In the News
USCT Financial details
Company Rating
Sell
Market Cap
86.59M
Income
4.4M
Revenue
0
Book val./share
2.51
Cash/share
2.85
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
20.03
Forward P/E
-
PEG
0
P/S
-
P/B
4.36
P/C
3.91
P/FCF
-103.26
Quick Ratio
23.79
Current Ratio
0.18
Debt / Equity
0.02
LT Debt / Equity
-
-
-
EPS (TTM)
12.44M
EPS next Y
-
EPS next Q
1.57
EPS this Y
1340%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-124.62%
-
-
-
-
SMA20
1.28%
SMA50
1.93%
SMA100
2.49%
Inst Own
15.4%
Inst Trans
0.54%
ROA
19%
ROE
6%
ROC
-0.24%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
7.79M
Shs Float
2.55M
-
-
-
-
Target Price
-
52W Range
10.39-11.24
52W High
+1.36%
52W Low
+11.5%
RSI
65.37
Rel Volume
0.02
Avg Volume
19.87K
Volume
377
Perf Week
0.81%
Perf Month
1.64%
Perf Quarter
-
Perf Half Y
3.34%
-
-
-
-
Beta
-0.001
-
-
Volatility
0.02%, 0.07%
Prev Close
0%
Price
11.15
Change
0.18%
USCT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | 0.3 | 4.32 | |
Operating cash flow per share | -0.03 | -0.11 | |
Free cash flow per share | -0.03 | -0.11 | |
Cash per share | 0.03 | 41.41 | |
Book value per share | 7.52 | 39.57 | |
Tangible book value per share | 7.52 | 39.57 | |
Share holders equity per share | 7.52 | 39.57 | |
Interest debt per share | 0 | -2.36 | |
Market cap | 285.06M | 59.23M | |
Enterprise value | 284.31M | 59.1M | |
P/E ratio | 32.98 | 2.39 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -340.22 | -97.69 | |
PFCF ratio | -340.22 | -97.69 | |
P/B Ratio | 1.32 | 0.26 | |
PTB ratio | 1.32 | 0.26 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -156.45 | -4.72 | |
EV to operating cash flow | -339.33 | -97.49 | |
EV to free cash flow | -339.33 | -97.49 | |
Earnings yield | 0.03 | 0.42 | |
Free cash flow yield | 0 | -0.01 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 0.41 | 0.01 | |
Current ratio | 3.3 | 0.28 | |
Interest coverage | 0 | 0.17 | |
Income quality | -0.1 | -0.05 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 7.13 | 62 | |
ROIC | -0.01 | -0.02 | |
Return on tangible assets | 0.04 | 0.1 | |
Graham Net | -0.66 | 39.51 | |
Working capital | 813.66K | -1.2M | |
Tangible asset value | 216.26M | 227.51M | |
Net current asset value | -18.67M | -10.48M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 798.43K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 247.16 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 1.48 | |
Inventory turnover | 0 | 0 | |
ROE | 0.04 | 0.11 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.22 | 12.44M | -0.38 | 0.65 | -0.16 | |
Operating cash flow per share | 0 | -415.06K | -0.01 | -0.04 | -0.01 | |
Free cash flow per share | 0 | -415.06K | -0.01 | -0.04 | -0.01 | |
Cash per share | 8.22 | 610.54M | 3.37 | 3.17 | 2.85 | |
Book value per share | 7.85 | 583.35M | 2.4 | 1.92 | 2.51 | |
Tangible book value per share | 7.85 | 583.35M | 2.4 | 1.92 | 2.51 | |
Share holders equity per share | 7.85 | 583.35M | 2.4 | 1.92 | 2.51 | |
Interest debt per share | -0.11 | -7.84M | 0.12 | -0.01 | 0.05 | |
Market cap | 291.35M | 4.02 | 178.12M | 118.78M | 86.89M | |
Enterprise value | 291.07M | -124.23K | 177.94M | 118.78M | 87.22M | |
P/E ratio | 11.65 | 0 | -6.89 | 4.08 | -17.14 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -4.21K | 0 | -1.37K | -280.31 | -787.02 | |
PFCF ratio | -4.21K | 0 | -1.37K | -280.31 | -787.02 | |
P/B Ratio | 1.29 | 0 | 4.34 | 5.52 | 4.29 | |
PTB ratio | 1.29 | 0 | 4.34 | 5.52 | 4.29 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -114.75 | 0.05 | -1.21K | -34.21 | 127.59 | |
EV to operating cash flow | -4.21K | 0.77 | -1.36K | -280.31 | -789.93 | |
EV to free cash flow | -4.21K | 0.77 | -1.36K | -280.31 | -789.93 | |
Earnings yield | 0.02 | 1.21M | -0.04 | 0.06 | -0.01 | |
Free cash flow yield | 0 | -40.3K | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0.01 | 0 | 0.02 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.02 | |
Net debt to EBITDA | 0.11 | 0.05 | 1.18 | 0 | 0.47 | |
Current ratio | 1.06 | 0.28 | 0.14 | 0.99 | 0.18 | |
Interest coverage | 0.1 | 0.41 | -1.6 | 0 | 0 | |
Income quality | -0.02 | -0.09 | 0.03 | -0.06 | 0.09 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.2 | 404.1M | 4.51 | 5.29 | 2.98 | |
ROIC | 0 | -0.02 | -0.1 | -0.04 | -0.02 | |
Return on tangible assets | 0.03 | 0.02 | -0.11 | 0.13 | -0.06 | |
Graham Net | 7.84 | 582.49M | 2.38 | -0.09 | 2.5 | |
Working capital | 40.36K | -1.2M | -4.08M | -254.29K | -792.31K | |
Tangible asset value | 225.71M | 227.51M | 41.04M | 21.51M | 20.24M | |
Net current asset value | -10.32M | -10.48M | -16.21M | -879.51K | -2.6M | |
Invested capital | 0 | 0 | 0.01 | 0 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 515.08K | 1.08M | 2.9M | 2.27M | 437.49K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 166.47 | 60.94 | 131.89 | 38.3 | 107.84 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.54 | 1.48 | 0.68 | 2.35 | 0.83 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.02 | -0.16 | 0.34 | -0.06 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
USCT Frequently Asked Questions
What is TKB Critical Technologies 1 stock symbol ?
TKB Critical Technologies 1 is a US stock , located in El segundo of Ca and trading under the symbol USCT
What is TKB Critical Technologies 1 stock quote today ?
TKB Critical Technologies 1 stock price is $11.15 today.
Is TKB Critical Technologies 1 stock public?
Yes, TKB Critical Technologies 1 is a publicly traded company.